Cargando…

The pioneer factor activity of c-Myb involves recruitment of p300 and induction of histone acetylation followed by acetylation-induced chromatin dissociation

BACKGROUND: The concept of pioneer transcription factors is emerging as an essential part of the epigenetic regulation, taking place during cell development and differentiation. However, the precise molecular mechanism underlying pioneer factor activity remains poorly understood. We recently reporte...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuglerud, Bettina M., Ledsaak, Marit, Rogne, Marie, Eskeland, Ragnhild, Gabrielsen, Odd S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022509/
https://www.ncbi.nlm.nih.gov/pubmed/29954426
http://dx.doi.org/10.1186/s13072-018-0208-y
_version_ 1783335693085310976
author Fuglerud, Bettina M.
Ledsaak, Marit
Rogne, Marie
Eskeland, Ragnhild
Gabrielsen, Odd S.
author_facet Fuglerud, Bettina M.
Ledsaak, Marit
Rogne, Marie
Eskeland, Ragnhild
Gabrielsen, Odd S.
author_sort Fuglerud, Bettina M.
collection PubMed
description BACKGROUND: The concept of pioneer transcription factors is emerging as an essential part of the epigenetic regulation, taking place during cell development and differentiation. However, the precise molecular mechanism underlying pioneer factor activity remains poorly understood. We recently reported that the transcription factor c-Myb acts as a pioneer factor in haematopoiesis, and a point mutation in its DNA binding domain, D152V, is able to abrogate this function. RESULTS: Here, we show that specific histone modifications, including H3K27ac, prevent binding of c-Myb to histone tails, representing a novel effect of histone modifications, namely restricting binding of a pioneer factor to chromatin. Furthermore, we have taken advantage of the pioneer-defect D152V mutant to investigate mechanisms of c-Myb’s pioneer factor activity. We show that c-Myb-dependent transcriptional activation of a gene in inaccessible chromatin relies on c-Myb binding to histones, as well as on c-Myb interacting with the histone acetyltransferase p300. ChIP assays show that both wild type and the D152V mutant of c-Myb bind to a selected target gene at its promoter and enhancer, but only wild-type c-Myb causes opening and activation of the locus. Enhancement of histone acetylation restores activation of the same gene in the absence of c-Myb, suggesting that facilitating histone acetylation is a crucial part of the pioneer factor function of c-Myb. CONCLUSIONS: We suggest a pioneer factor model in which c-Myb binds to regions of closed chromatin and then recruits histone acetyltransferases. By binding to histones, c-Myb facilitates histone acetylation, acting as a cofactor for p300 at c-Myb bound sites. The resulting H3K27ac leads to chromatin opening and detachment of c-Myb from the acetylated chromatin. We propose that the latter phenomenon, acetylation-induced chromatin dissociation, represents a mechanism for controlling the dynamics of pioneer factor binding to chromatin. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13072-018-0208-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6022509
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60225092018-07-09 The pioneer factor activity of c-Myb involves recruitment of p300 and induction of histone acetylation followed by acetylation-induced chromatin dissociation Fuglerud, Bettina M. Ledsaak, Marit Rogne, Marie Eskeland, Ragnhild Gabrielsen, Odd S. Epigenetics Chromatin Research BACKGROUND: The concept of pioneer transcription factors is emerging as an essential part of the epigenetic regulation, taking place during cell development and differentiation. However, the precise molecular mechanism underlying pioneer factor activity remains poorly understood. We recently reported that the transcription factor c-Myb acts as a pioneer factor in haematopoiesis, and a point mutation in its DNA binding domain, D152V, is able to abrogate this function. RESULTS: Here, we show that specific histone modifications, including H3K27ac, prevent binding of c-Myb to histone tails, representing a novel effect of histone modifications, namely restricting binding of a pioneer factor to chromatin. Furthermore, we have taken advantage of the pioneer-defect D152V mutant to investigate mechanisms of c-Myb’s pioneer factor activity. We show that c-Myb-dependent transcriptional activation of a gene in inaccessible chromatin relies on c-Myb binding to histones, as well as on c-Myb interacting with the histone acetyltransferase p300. ChIP assays show that both wild type and the D152V mutant of c-Myb bind to a selected target gene at its promoter and enhancer, but only wild-type c-Myb causes opening and activation of the locus. Enhancement of histone acetylation restores activation of the same gene in the absence of c-Myb, suggesting that facilitating histone acetylation is a crucial part of the pioneer factor function of c-Myb. CONCLUSIONS: We suggest a pioneer factor model in which c-Myb binds to regions of closed chromatin and then recruits histone acetyltransferases. By binding to histones, c-Myb facilitates histone acetylation, acting as a cofactor for p300 at c-Myb bound sites. The resulting H3K27ac leads to chromatin opening and detachment of c-Myb from the acetylated chromatin. We propose that the latter phenomenon, acetylation-induced chromatin dissociation, represents a mechanism for controlling the dynamics of pioneer factor binding to chromatin. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13072-018-0208-y) contains supplementary material, which is available to authorized users. BioMed Central 2018-06-28 /pmc/articles/PMC6022509/ /pubmed/29954426 http://dx.doi.org/10.1186/s13072-018-0208-y Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Fuglerud, Bettina M.
Ledsaak, Marit
Rogne, Marie
Eskeland, Ragnhild
Gabrielsen, Odd S.
The pioneer factor activity of c-Myb involves recruitment of p300 and induction of histone acetylation followed by acetylation-induced chromatin dissociation
title The pioneer factor activity of c-Myb involves recruitment of p300 and induction of histone acetylation followed by acetylation-induced chromatin dissociation
title_full The pioneer factor activity of c-Myb involves recruitment of p300 and induction of histone acetylation followed by acetylation-induced chromatin dissociation
title_fullStr The pioneer factor activity of c-Myb involves recruitment of p300 and induction of histone acetylation followed by acetylation-induced chromatin dissociation
title_full_unstemmed The pioneer factor activity of c-Myb involves recruitment of p300 and induction of histone acetylation followed by acetylation-induced chromatin dissociation
title_short The pioneer factor activity of c-Myb involves recruitment of p300 and induction of histone acetylation followed by acetylation-induced chromatin dissociation
title_sort pioneer factor activity of c-myb involves recruitment of p300 and induction of histone acetylation followed by acetylation-induced chromatin dissociation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022509/
https://www.ncbi.nlm.nih.gov/pubmed/29954426
http://dx.doi.org/10.1186/s13072-018-0208-y
work_keys_str_mv AT fuglerudbettinam thepioneerfactoractivityofcmybinvolvesrecruitmentofp300andinductionofhistoneacetylationfollowedbyacetylationinducedchromatindissociation
AT ledsaakmarit thepioneerfactoractivityofcmybinvolvesrecruitmentofp300andinductionofhistoneacetylationfollowedbyacetylationinducedchromatindissociation
AT rognemarie thepioneerfactoractivityofcmybinvolvesrecruitmentofp300andinductionofhistoneacetylationfollowedbyacetylationinducedchromatindissociation
AT eskelandragnhild thepioneerfactoractivityofcmybinvolvesrecruitmentofp300andinductionofhistoneacetylationfollowedbyacetylationinducedchromatindissociation
AT gabrielsenodds thepioneerfactoractivityofcmybinvolvesrecruitmentofp300andinductionofhistoneacetylationfollowedbyacetylationinducedchromatindissociation
AT fuglerudbettinam pioneerfactoractivityofcmybinvolvesrecruitmentofp300andinductionofhistoneacetylationfollowedbyacetylationinducedchromatindissociation
AT ledsaakmarit pioneerfactoractivityofcmybinvolvesrecruitmentofp300andinductionofhistoneacetylationfollowedbyacetylationinducedchromatindissociation
AT rognemarie pioneerfactoractivityofcmybinvolvesrecruitmentofp300andinductionofhistoneacetylationfollowedbyacetylationinducedchromatindissociation
AT eskelandragnhild pioneerfactoractivityofcmybinvolvesrecruitmentofp300andinductionofhistoneacetylationfollowedbyacetylationinducedchromatindissociation
AT gabrielsenodds pioneerfactoractivityofcmybinvolvesrecruitmentofp300andinductionofhistoneacetylationfollowedbyacetylationinducedchromatindissociation